Q3 2026 13F filing
Updated 15 days ago44 disclosed positions worth $145.8M
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | E ISHARES TR | $70.5M | 700.0K | 48.33% | Unchanged |
| 2 | S SPDR SERIES TRUST | $60.9M | 386.5K | 41.79% | Trimmed(-32.2%) |
| 3 | S SERA PROGNOSTICS INC | $5M | 2.40M | 3.43% | — |
| 4 | H HALOZYME THERAPEUTICS INC | $331K | 3.0K | 0.23% | Trimmed(-57.1%) |
| 5 | M MADRIGAL PHARMACEUTICALS INC | $302K | 600 | 0.21% | Unchanged |
| 6 | E EXELIXIS INC | $292K | 5.0K | 0.20% | Trimmed(-37.5%) |
| 7 | R ROYALTY PHARMA PLC | $292K | 5.0K | 0.20% | Trimmed(-54.5%) |
| 8 | A ARGENX SE | $288K | 300 | 0.20% | Trimmed(-53.2%) |
| 9 | N NURIX THERAPEUTICS INC | $285K | 12.0K | 0.20% | Trimmed(-52.0%) |
| 10 | T TG THERAPEUTICS INC | $279K | 5.0K | 0.19% | Trimmed(-50.0%) |
| 11 | T TARSUS PHARMACEUTICALS INC | $275K | 3.5K | 0.19% | Trimmed(-50.0%) |
| 12 | H HARMONY BIOSCIENCES HLDGS IN | $275K | 7.0K | 0.19% | Trimmed(-30.0%) |
| 13 | A ARCUTIS BIOTHERAPEUTICS INC | $264K | 10.0K | 0.18% | Trimmed(-49.2%) |
| 14 | K KINIKSA PHARMACEUTICALS INTL | $261K | 3.5K | 0.18% | Trimmed(-30.0%) |
| 15 | S SUPERNUS PHARMACEUTICALS | $258K | 6.0K | 0.18% | Unchanged |
| 16 | I IMMUNOME INC | $258K | 12.0K | 0.18% | Trimmed(-33.3%) |
| 17 | N NEUROCRINE BIOSCIENCES INC | $255K | 1.8K | 0.18% | Trimmed(-40.0%) |
| 18 | O ORUKA THERAPEUTICS INC | $250K | 3.0K | 0.17% | Unchanged |
| 19 | T TANGO THERAPEUTICS INC | $250K | 10.0K | 0.17% | Unchanged |
| 20 | D DEFINIUM THERAPEUTICS INC | $247K | 6.5K | 0.17% | Trimmed(-35.0%) |
| 21 | R REVOLUTION MEDICINES INC | $246K | 1.2K | 0.17% | Unchanged |
| 22 | A ALKERMES PLC | $243K | 6.0K | 0.17% | Unchanged |
| 23 | A AURINIA PHARMACEUTICALS INC | $243K | 15.0K | 0.17% | Trimmed(-50.0%) |
| 24 | I INCYTE CORP | $243K | 2.0K | 0.17% | Trimmed(-62.3%) |
| 25 | N INTELLIA THERAPEUTICS INC | $241K | 20.0K | 0.17% | Unchanged |
| 26 | I IMMUNOVANT INC | $236K | 7.0K | 0.16% | Trimmed(-46.1%) |
| 27 | S STOKE THERAPEUTICS INC | $234K | 9.0K | 0.16% | Trimmed(-25.0%) |
| 28 | K KRYSTAL BIOTECH INC | $230K | 692 | 0.16% | Unchanged |
| 29 | A ASCENDIS PHARMA A/S | $228K | 1.0K | 0.16% | Trimmed(-33.3%) |
| 30 | S SYNDAX PHARMACEUTICALS INC | $226K | 12.0K | 0.15% | Trimmed(-40.0%) |
| 31 | K KYMERA THERAPEUTICS INC | $224K | 2.0K | 0.15% | Trimmed(-50.0%) |
| 32 | D DIANTHUS THERAPEUTICS INC | $220K | 2.5K | 0.15% | Unchanged |
| 33 | T TREVI THERAPEUTICS INC | $215K | 15.0K | 0.15% | Trimmed(-50.0%) |
| 34 | M MIRUM PHARMACEUTICALS INC | $214K | 2.5K | 0.15% | Unchanged |
| 35 | I IMMUNOCORE HLDGS PLC | $212K | 7.0K | 0.15% | Trimmed(-53.8%) |
| 36 | P PROTAGONIST THERAPEUTICS INC | $211K | 1.5K | 0.14% | Trimmed(-50.0%) |
| 37 | E EDGEWISE THERAPEUTICS INC | $203K | 5.0K | 0.14% | Unchanged |
| 38 | O ORIC PHARMACEUTICALS INC | $175K | 13.0K | 0.12% | Unchanged |
| 39 | D DYNE THERAPEUTICS INC | $161K | 10.0K | 0.11% | Trimmed(-50.0%) |
| 40 | C COMPASS PATHWAYS PLC | $124K | 10.0K | 0.09% | Trimmed(-44.4%) |
| 41 | O OCULAR THERAPEUTIX INC | $115K | 15.0K | 0.08% | Unchanged |
| 42 | C CYTOMX THERAPEUTICS INC. | $107K | 39.4K | 0.07% | Unchanged |
| 43 | A ARDELYX INC | $103K | 30.0K | 0.07% | Trimmed(-50.0%) |
| 44 | O OLEMA PHARMACEUTICALS INC | $86K | 10.0K | 0.06% | Unchanged |